136 related articles for article (PubMed ID: 9138445)
21. New developments in viral peptides and APL induction.
Gharavi AE; Pierangeli SS; Harris EN
J Autoimmun; 2000 Sep; 15(2):227-30. PubMed ID: 10968915
[TBL] [Abstract][Full Text] [Related]
22. Are anti-beta-glycoprotein-I antibodies markers for recurrent pregnancy loss in lupus anticoagulant/anticardiolipin seronegative women?
Alijotas-Reig J; Casellas-Caro M; Ferrer-Oliveras R; Llurba-Olive E; Hermosilla E; Vilardell-Tarres M; Cabero-Roura L
Am J Reprod Immunol; 2008 Sep; 60(3):229-37. PubMed ID: 18782284
[TBL] [Abstract][Full Text] [Related]
23. Immunologic characterization and functional properties of murine antibodies raised against deleted mutants of human beta 2-glycoprotein I.
George J; Blank M; Gilburd B; Hojnik M; Shenkman B; Tamarin I; Varon D; Matsuura E; Koike T; Shoenfeld Y
Int Immunol; 1997 Jun; 9(6):913-21. PubMed ID: 9199975
[TBL] [Abstract][Full Text] [Related]
24. The pathogenic role of anti-phosphatidylserine antibodies: active immunization with the antibodies leads to the induction of antiphospholipid syndrome.
Yodfat O; Blank M; Krause I; Shoenfeld Y
Clin Immunol Immunopathol; 1996 Jan; 78(1):14-20. PubMed ID: 8599879
[TBL] [Abstract][Full Text] [Related]
25. Intrauterine fetal death in mice caused by cytomegalovirus-derived peptide induced aPL antibodies.
Gharavi AE; Vega-Ostertag M; Espinola RG; Liu X; Cole L; Cox NT; Romagnoli P; Labat K; Pierangeli SS
Lupus; 2004; 13(1):17-23. PubMed ID: 14870913
[TBL] [Abstract][Full Text] [Related]
26. Specificity of ELISA for antibody to beta 2-glycoprotein I in patients with antiphospholipid syndrome.
Amengual O; Atsumi T; Khamashta MA; Koike T; Hughes GR
Br J Rheumatol; 1996 Dec; 35(12):1239-43. PubMed ID: 9010050
[TBL] [Abstract][Full Text] [Related]
27. Antiphospholipid, anti-beta 2-glycoprotein-I and anti-oxidized-low-density-lipoprotein antibodies in antiphospholipid syndrome.
Cuadrado MJ; Tinahones F; Camps MT; de Ramon E; Gómez-Zumaquero JM; Mujic F; Khamashta MA; Hughes GR
QJM; 1998 Sep; 91(9):619-26. PubMed ID: 10024916
[TBL] [Abstract][Full Text] [Related]
28. Prevalence of antibodies to beta2-glycoprotein I in systemic lupus erythematosus and their association with antiphospholipid antibody syndrome criteria: a single center study and literature review.
Bruce IN; Clark-Soloninka CA; Spitzer KA; Gladman DD; Urowitz MB; Laskin CA
J Rheumatol; 2000 Dec; 27(12):2833-7. PubMed ID: 11128672
[TBL] [Abstract][Full Text] [Related]
29. Autoreactive CD4(+) T cells to beta(2)-glycoprotein I in patients with antiphospholipid syndrome.
Kuwana M
Autoimmun Rev; 2003 Jun; 2(4):192-8. PubMed ID: 12848945
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of ras by farnesylthiosalicylate significantly reduces the levels of autoantibodies in two animal models of the antiphospholipid syndrome.
Katzav A; Kloog Y; Korczyn AD; Molina V; Blank M; Shoenfeld Y; Chapman J
Immunobiology; 2003; 207(1):47-50. PubMed ID: 12638903
[TBL] [Abstract][Full Text] [Related]
31. Phospholipid-dependent anti-beta 2-glycoprotein I (beta 2-GPI) antibodies and antiphospholipid syndrome.
Kaburaki J; Kuwana M; Yamamoto M; Kawai S; Matsuura E; Ikeda Y
Intern Med; 1996 Feb; 35(2):105-10. PubMed ID: 8680096
[TBL] [Abstract][Full Text] [Related]
32. Lessons from experimental APS models.
Shoenfeld Y; Ziporen L
Lupus; 1998; 7 Suppl 2():S158-61. PubMed ID: 9814695
[TBL] [Abstract][Full Text] [Related]
33. beta 2-Glycoprotein I and anti-beta 2-glycoprotein I antibodies: where are we now?
Inanç M; Radway-Bright EL; Isenberg DA
Br J Rheumatol; 1997 Dec; 36(12):1247-57. PubMed ID: 9448584
[TBL] [Abstract][Full Text] [Related]
34. Induction of phospholipid-binding antibodies in mice and rabbits by immunization with human beta 2 glycoprotein 1 or anticardiolipin antibodies alone.
Pierangeli SS; Harris EN
Clin Exp Immunol; 1993 Aug; 93(2):269-72. PubMed ID: 8348755
[TBL] [Abstract][Full Text] [Related]
35. Anti-beta2-glycoprotein I autoantibodies, in vitro thrombin generation, and the antiphospholipid syndrome.
Hanly JG; Smith SA
J Rheumatol; 2000 Sep; 27(9):2152-9. PubMed ID: 10990227
[TBL] [Abstract][Full Text] [Related]
36. Clinical significance of phospholipid-dependent anti-beta 2-glycoprotein I (beta 2-GPI) antibodies in systemic lupus erythematosus.
Kaburaki J; Kuwana M; Yamamoto M; Kawai S; Matsuura E; Ikeda Y
Lupus; 1995 Dec; 4(6):472-6. PubMed ID: 8749570
[TBL] [Abstract][Full Text] [Related]
37. Cross-reactivity between annexin A2 and Beta-2-glycoprotein I in animal models of antiphospholipid syndrome.
Weiss R; Bitton A; Nahary L; Arango MT; Benhar I; Blank M; Shoenfeld Y; Chapman J
Immunol Res; 2017 Feb; 65(1):355-362. PubMed ID: 27449504
[TBL] [Abstract][Full Text] [Related]
38. Induction of APS after TTd hyper-immunization has a different outcome in BALB/c and C57BL/6 mice.
Zivkovic I; Stojanovic M; Petrusic V; Inic-Kanada A; Dimitrijevic L
Am J Reprod Immunol; 2011 May; 65(5):492-502. PubMed ID: 21029246
[TBL] [Abstract][Full Text] [Related]
39. Do patients with antiphospholipid syndrome have autoantibodies to beta 2-glycoprotein I?
Gharavi AE; Harris EN; Sammaritano LR; Pierangeli SS; Wen J
J Lab Clin Med; 1993 Oct; 122(4):426-31. PubMed ID: 8228557
[TBL] [Abstract][Full Text] [Related]
40. Pathogenesis of antiphospholipid antibodies: impairment of fibrinolysis and monocyte activation via the p38 mitogen-activated protein kinase pathway.
Yasuda S; Bohgaki M; Atsumi T; Koike T
Immunobiology; 2005; 210(10):775-80. PubMed ID: 16325497
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
